The core activity of Tecrapharm is the international commercialization of pharmaceuticals, particularly through:
* Registration and marketing of pharmaceuticals as the holder of a marketing authorization in selected territories
* Provision of pharmaceuticals in countries where they are not yet commercially available through Managed Access Programs
* Ensuring the continuous availability of essential medicines, even in times of supply chain disruptions
* Offering services such as distribution, storage, medico-marketing, and regulatory strategy for pharmaceutical and biotech companies.
The company focuses on innovative therapies and essential medicines, covering over 105 countries with its network.